Tenon Medical, Inc. TNON
Tenon Medical, Inc. (Nasdaq: TNON) is a pain/anesthesia medical device company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| The Catamaran SI Joint Fusion System | SI joint fusion | — | NA_NON_THERAPEUTIC |
| The SImmetry+ SI Joint Fusion System | SI joint fusion (acquired Aug 2025) | — | NA_NON_THERAPEUTIC |
Recent results and decisions
- Oct 16, 2026n/a Tenon Medical issued Series B warrants to purchase 125,000 shares of common stock at $5.02 exercise price to investor in exchange for waiver of restrictions on at-the-market offering.
As consideration for the Investor Waiver, the Company issued to the Investor a Series B common stock purchase warrant to purchase up to 125,000 shares of Common Stock, which has an exercise price of $5.02 per share and expiration date of September 14, 2031.
Filing
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other pain/anesthesia companies
- Aclarion, Inc. ACON
- Autonomix Medical, Inc. AMIX
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.